Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18359628rdf:typepubmed:Citationlld:pubmed
pubmed-article:18359628lifeskim:mentionsumls-concept:C0346647lld:lifeskim
pubmed-article:18359628lifeskim:mentionsumls-concept:C0005682lld:lifeskim
pubmed-article:18359628lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:18359628lifeskim:mentionsumls-concept:C1516170lld:lifeskim
pubmed-article:18359628lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:18359628lifeskim:mentionsumls-concept:C0077938lld:lifeskim
pubmed-article:18359628lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:18359628pubmed:issue8lld:pubmed
pubmed-article:18359628pubmed:dateCreated2008-4-15lld:pubmed
pubmed-article:18359628pubmed:abstractTextDerivatives of oleanolic acid, ursolic acid and glycyrrhetinic acid substituted with electron-withdrawing groups at the 2-position in the A-ring which also contains a 1-en-3-one structure are potent inhibitors of cancer cell growth. In this study, we have compared the effects of several 2-substituted analogs of triterpenoid acid methyl esters derived from ursolic and glycyrrhetinic acid on proliferation of KU7 and 253JB-V bladder and Panc-1 and Panc-28 pancreatic cancer cells. The results show that the 2-cyano and 2-trifluoromethyl derivatives were the most active compounds. The glycyrrhetinic acid derivatives with the rearranged C-ring containing the 9(11)-en-12-one structure were generally more active than the corresponding 12-en-11-one isomers. However, differences in growth inhibitory IC(50) values were highly variable and dependent on the 2-substituent (CN vs CF(3)) and cancer cell context.lld:pubmed
pubmed-article:18359628pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:languageenglld:pubmed
pubmed-article:18359628pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:citationSubsetIMlld:pubmed
pubmed-article:18359628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18359628pubmed:statusMEDLINElld:pubmed
pubmed-article:18359628pubmed:monthAprlld:pubmed
pubmed-article:18359628pubmed:issn1464-3405lld:pubmed
pubmed-article:18359628pubmed:authorpubmed-author:SafeStephenSlld:pubmed
pubmed-article:18359628pubmed:authorpubmed-author:McAleesAlanAlld:pubmed
pubmed-article:18359628pubmed:authorpubmed-author:JutooruIndira...lld:pubmed
pubmed-article:18359628pubmed:authorpubmed-author:ChadalapakaGa...lld:pubmed
pubmed-article:18359628pubmed:authorpubmed-author:StefanacTomTlld:pubmed
pubmed-article:18359628pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18359628pubmed:day15lld:pubmed
pubmed-article:18359628pubmed:volume18lld:pubmed
pubmed-article:18359628pubmed:ownerNLMlld:pubmed
pubmed-article:18359628pubmed:authorsCompleteYlld:pubmed
pubmed-article:18359628pubmed:pagination2633-9lld:pubmed
pubmed-article:18359628pubmed:dateRevised2011-4-4lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:meshHeadingpubmed-meshheading:18359628...lld:pubmed
pubmed-article:18359628pubmed:year2008lld:pubmed
pubmed-article:18359628pubmed:articleTitleStructure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives.lld:pubmed
pubmed-article:18359628pubmed:affiliationDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843-4466, USA.lld:pubmed
pubmed-article:18359628pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18359628pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18359628pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18359628lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18359628lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18359628lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18359628lld:pubmed